- Posted by atatarko
- 0 Comments
IRVING, Tex., Jan. 11, 2016 – Caris Life Sciences®, a leading biotechnology company focused on fulfilling the promise of precision medicine.
Announces today that David D. Halbert, Chairman and Chief Executive Officer, will present at the 34th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2016 at 10:30 a.m. PST in San Francisco, Calif. Company management will discuss its two proprietary technology platforms, Caris Molecular Intelligence® and ADAPT Biotargeting System™, in addition to taking questions from the audience.
To view the full text of the article click here